T1	p 86 116	atrial fibrillation patients :
T2	p 254 255	(
T3	p 260 261	)
T4	p 402 413	individuals
T5	p 461 465	In a
T6	p 527 548	cases with stroke and
T7	p 555 568	with bleeding
T8	p 585 608	matched with controls .
T9	p 715 763	32 cases with ischemic stroke and 234 cases with
T10	p 981 991	respective
T11	p 1501 1527	AF patients with stroke or
T12	p 1559 1567	controls
T13	i 28 39	INR control
T14	i 260 261	)
T15	i 312 319	control
T16	i 683 706	time-dependent manner .
T17	o 17 39	individual INR control
T18	o 48 82	risk of stroke and bleeding events
T19	o 193 261	therapeutic range ( TTR ) for international normalized ratio ( INR )
T20	o 379 398	stroke and bleeding
T21	o 617 649	anticoagulation quality measures
T22	o 764 772	bleeding
T23	o 868 876	duration
T24	o 1013 1029	mean TTR of both
T25	o 1090 1104	bleeding cases
T26	o 1173 1178	range
T27	o 1183 1189	stroke
T28	o 1205 1210	range
T29	o 1215 1223	bleeding
T30	o 1368 1395	cases spent more time below
T31	o 1473 1476	TTR
T32	o 1525 1536	or bleeding
T33	o 1571 1577	ACTIVE
T34	o 1595 1599	high
T35	o 1641 1649	and high
T36	o 1719 1740	stroke and bleeding .